Striatal creatine and glutamate/glutamine in attention-deficit/ hyperactivity disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 17, Issue 1, 2007, Pages 11-17

  Carrey, Normand J ^a,c   MacMaster, Frank P ^a,b   Gaudet, Laura ^a   Schmidt, Matthias H ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c IWK HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; GLUTAMIC ACID; GLUTAMINE; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

AMINO ACID ANALYSIS; AMINO ACID BRAIN LEVEL; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILD PSYCHIATRY; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; HUMAN; MALE; NEUROCHEMISTRY; OCCIPITAL LOBE; PREFRONTAL CORTEX; PROTON NUCLEAR MAGNETIC RESONANCE; TREATMENT OUTCOME;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHOLINE; CORPUS STRIATUM; CREATINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTAMIC ACID; GLUTAMINE; HUMANS; INOSITOL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METHYLPHENIDATE; NEURAL PATHWAYS; OCCIPITAL LOBE; PHOSPHOCREATINE; PREFRONTAL CORTEX; REFERENCE VALUES;

EID: 33947381057     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2006.0008     Document Type: Article

References (36)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Washington (DC), American Psychiatric Association, 1994.
2. Barbour B: An evaluation of synapse independence. J Neurosci 21:7969-7984, 2001.
3. Barkley RA: Attention-deficit hyperactivity disorder. In: Child Psychopathology. Edited by Mash EJ, Barkley RA. New York, Guilford Press, 1996, pp 63-112.
4. Brustovetsky N, Brustovetsky T, Dubinsky JM: On the mechanisms of neuroprotection by creatine and phosphocreatine. J Neurochem 76:425-434, 2001.
5. Carrey N, MacMaster FP, Sparkes SJ, Khan SC, Kusumakar V: Glutamatergic changes with treatment in attention deficit hyperactivity disorder: A preliminary case series. J Child Adolesc Psychopharmacol 12:331-336, 2002.
6. Carrey N, MacMaster FP, Fogel J, Sparkes S, Waschbusch D, Sullivan S, Schmidt M: Metabolite changes resulting from treatment in children with ADHD: A 1H-MRS study. Clin Neuropharmacol 26:218-221, 2003.
7. Conners CK: Conners' Rating Scales. North Tonawanda (NY), Multi-Health Systems, 1990.
8. Courvoisie H, Hooper SR, Fine C, Kwock L, Castillo M: Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: Preliminary findings. J Neuropsychiatry Clin Neurosci 16:63-69, 2004.
9. Durston S, Tottenham NT, Thomas KM, Davidson MC, Eigsti IM, Yang Y, Ulug AM, Casey BJ: Differential patterns of striatal activation in young children with and without ADHD. Biol Psychiatry 53(10):871-878, 2003.
10. Greenhill LL: Diagnosing attention-deficit/hyperactivity disorder in children. J Clin Psychiatry 59 (Suppl) 7:31-41, 1998.
11. Hesslinger B, Thiel T, Tebartz van Elst L, Hennig J, Ebert D: Attention-deficit disorder in adults with or without hyperactivity: Where is the difference? A study in humans using short echo (1)H-magnetic resonance spectroscopy. Neurosci Lett 304:117-119, 2001.
12. Hinshaw SP: Externalizing behavior problems and academic underachievement in childhood and adolescence: Causal relationships and underlying mechanisms. Psychol Bull 111:127-155, 1992.
13. Jin Z, Zang YF, Zeng YW, Zhang L, Wang YF: Striatal neuronal loss or dysfunction and choline rise in children with attention-deficit hyperactivity disorder: A 1H-magnetic resonance spectroscopy study. Neurosci Lett 315:45-48, 2001.
14. Kalivas PW, Duffy P, Barrow J: Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J Pharmacol Exp Ther 251:378-387, 1989.
15. Kanowski M, Kaufmann J, Braun J, Bernarding J, Tempelmann C: Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES. Magn Reson Med 51:904-912, 2004.
16. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36: 980-988, 1997.
17. Kornhuber ME, Kornhuber J, Retz W, Riederer P: L-glutamate and L-aspartate concentrations in the developing and aging human putamen tissue. J Neural Transm Gen Sect 93:145-150, 1993.
18. Lou HC, Henriksen L, Bruhn P, Borner H, Nielsen JB: Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch Neurol 46: 48-52, 1989.
19. MacMaster FP, Carrey N, Sparkes S, Kusumakar V: Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder. Biol Psychiatry 53:184-187, 2003.
20. MacMaster FP, Carrey NJ, Schmidt MH: Reproducibility of 1H-MRS in Children. Annual Meeting. Toronto, ON, International Society for Magnetic Resonance in Medicine, 2003.
21. National Institute of Mental Health: Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol Bull 21:713-1124, 1985.
22. Pliszka SR, Liotti M, Woldorff MG: Inhibitory control in children with attention-deficit/hyperactivity disorder: Event-related potentials identify the processing component and timing of an impaired right-frontal response-inhibition mechanism. Biol Psychiatry 48:238-246, 2000.
23. Popper CW: Disorders usually first evident in infancy, childhood, or adolescence. In: Textbook of Psychiatry. Edited by Talbott JA, Hales RE, Yudofsky SC. Washington (DC) American Psychiatric Press, 1988, pp 649-735.
24. Provencher SW: Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672-679, 1993.
25. Provencher SW: Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 14:260-264, 2001.
26. Rubia K, Overmeyer S, Taylor E, Brammer M, Williams SC, Simmons A, Bullmore ET: Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: A study with functional MRI. Am J Psychiatry 156: 891-896, 1999.
27. Russell VA: Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder - the spontaneously hypertensive rat. Neurosci Biobehav Rev 27:671-682, 2003a.
28. Russell VA: In vitro glutamate-stimulated release of dopamine from nucleus accumbens core and shell of spontaneously hypertensive rats. Metab Brain Dis 18:161-168, 2003b.
29. Slotkin TA, McCook EC, Ritchie JC, Carroll BJ, Seidler FJ: Serotonin transporter expression in rat brain regions and blood platelets: Aging and glucocorticoid effects. Biol Psychiatry 41:172-183, 1997.
30. Stanley JA, Kipp H, Greisenegger E, Panchalingam K, Pettegrew JW, Keshavan MS, Bukstein O: In vivo 31P spectroscopy evidence of different regional neurodevelopmental alterations in children with ADHD, in Society for Neuroscience. San Diego, CA, Society for Neuroscience, 2004.
31. Taber MT, Fibiger HC: Electrical stimulation of the medial prefrontal cortex increases dopamine release in the striatum. Neuropsychopharmacology 9:271-275, 1993.
32. Teicher MH, Anderson CM, Polcari A, Glod CA, Maas LC, Renshaw PF: Functional deficits in basal ganglia of children with attention-deficit/ hyperactivity disorder shown with functional magnetic resonance imaging relaxometry. Nature Med 6:470-473, 2000.
33. Todd RD, Botteron KN: Is attention-deficit/hyperactivity disorder an energy deficiency syndrome? Biol Psychiatry 50:151-158, 2001.
34. Trudeau LE: Glutamate co-transmission as an emerging concept in monoamine neuron function. J Psychiatry Neurosci 29:296-310, 2004.
35. Xu CJ, Klunk WE, Kanfer JN, Xiong Q, Miller G, Pettegrew JW: Phosphocreatine-dependent glutamate uptake by synaptic vesicles. A comparison with ATP-dependent glutamate uptake. J Biol Chem 271:13435-13440, 1996.
36. Yeo RA, Hill DE, Campbell RA, Vigil J, Petropoulos H, Hart B, Zamora L, Brooks WM: Proton magnetic resonance spectroscopy investigation of the right frontal lobe in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 42:303-310, 2003.